Sign In
Buy TRCK
$0.640
+0 (+0%)
At Close: Jun 03, 2026
Verve Therapeutics: FDA Fast Track And Eli Lilly Partnership Upgrade It To A 'Buy'
10:56am, Wednesday, 16'th Apr 2025
VERV's VERVE-102 showed an impressive 69% LDL-C reduction in its early Phase 1b data. Also, LLY may opt into VERVE-102's development later this year, which would help VERV by covering one-third of the
Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer
08:00am, Wednesday, 16'th Apr 2025
GREENWICH, Conn.--(BUSINESS WIRE)--Deep Track Capital, LP, (together with its affiliates, “Deep Track” or “we”) is one of the largest shareholders of Dynavax Technologies Corporation (NASDAQ:
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therap
Arcturus Gets FDA's Fast Track Tag for Influenza Vaccine Candidate
12:50pm, Friday, 11'th Apr 2025
The FDA bestows a Fast Track designation to ARCT's sa-mRNA vaccine candidate, ARCT-2304, for active immunization to prevent pandemic influenza A virus H5N1.
Verve Therapeutics Receives U.S. FDA Fast Track Designation for VERVE-102, an In Vivo Base Editing Medicine Targeting PCSK9
07:00am, Friday, 11'th Apr 2025
BOSTON, April 11, 2025 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage company developing a new class of genetic medicines for cardiovascular disease, today announced that the U.S. Food and D
FDA Grants Three Fast Track Tags to Allogene's Autoimmune Disease Drug
07:50am, Tuesday, 08'th Apr 2025
The FDA's fast track designations will facilitate rapid development and expedited review of ALLO's autoimmune disease candidate.
S&P 500 on Track to Close in a Bear Market
10:38am, Monday, 07'th Apr 2025
Traders are bracing for a wild week on Wall Street. The S&P 500 Index has sunk 20% below its record high set less than two months ago, and is on track to enter its first bear market since the Covid pa
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloC
Pinnacle Food Group: Not A Buy Yet, But This AgTech IPO Is On The Right Track
04:25pm, Sunday, 06'th Apr 2025
Pinnacle Food Group, a hydroponic farming company, is preparing for its IPO amidst a volatile market, targeting urban households and communities with innovative indoor growing systems. The hydroponic
OKYO Pharma CEO discusses FDA Fast Track filing for urcosimod - ICYMI
09:08am, Saturday, 05'th Apr 2025
OKYO Pharma Ltd (NASDAQ:OKYO) CEO Gary Jacob talked with Proactive about the company's recent developments, including the formal naming of its drug candidate OK-101 as urcosimod. Jacob discussed the c
Penguin Solutions: Growth Momentum Still On Track
09:05am, Saturday, 05'th Apr 2025
I maintain a bullish rating on Penguin Solutions due to strong AI-related demand and solid financial performance, validated by 2Q25 results. PENG reported $366 million in revenue, up 28% y/y, with sig
Fast Track to AV1 with Beamr: High-Quality at a Fraction of the Cost
07:35am, Wednesday, 02'nd Apr 2025
Beamr will showcase its high-performance AV1 solutions, accelerated by NVIDIA GPUs, and with simple, competitive pricing, at the 2025 NAB Show in Las Vegas
VANCOUVER, British Columbia, March 31, 2025 (GLOBE NEWSWIRE) -- Endeavour Silver Corp. ("Endeavour" or the "Company") (NYSE: EXK; TSX: EDR) provides a construction progress update for its Terronera Pr
Intellia: Nex-Z Advancement Remains On Track With Expanded ATTRv-PN Indication
06:24am, Friday, 28'th Mar 2025
Intellia received RMAT designation from the FDA of nex-z for the treatment of patients with Transthyretin [ATTR] Amyloidosis with Cardiomyopathy. Global sales of the Transthyretin Amyloidosis market i
Intelligent Bio Solutions' FDA Clearance Process Remains on Track for 2025 U.S. Launch
09:00am, Tuesday, 25'th Mar 2025
NEW YORK, March 25, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive t
